Edition:
India

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

0.43USD
15 Dec 2017
Change (% chg)

$0.01 (+3.26%)
Prev Close
$0.42
Open
$0.42
Day's High
$0.44
Day's Low
$0.41
Volume
22,349
Avg. Vol
35,480
52-wk High
$1.89
52-wk Low
$0.32

Chart for

About

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral... (more)

Overall

Beta: 2.42
Market Cap(Mil.): $43.30
Shares Outstanding(Mil.): 75.98
Dividend: --
Yield (%): --

Financials

BRIEF-Dental Corporation posts qtrly ‍net profit of 12.4 mln baht

* Qtrly ‍ net profit 12.4 million baht versus 12.2 million baht Source text for Eikon: Further company coverage:

13 Nov 2017

BRIEF-Biolase announces commencement of rights offering

* Biolase announces commencement of rights offering Source text for Eikon: Further company coverage:

09 Nov 2017

BRIEF-Biolase reports Q3 non-GAAP loss per share $0.05

* Q3 revenue rose 18 percent to $10.8 million Source text for Eikon: Further company coverage:

02 Nov 2017

BRIEF-Biolase appoints Richard Lanman to board of directors

* Biolase - ‍Lanman replaces outgoing director Fredrick Moll​ Source text for Eikon: Further company coverage:

31 Oct 2017

BRIEF-Biolase announces record date for previously announced proposed rights offering

* Biolase announces record date for previously announced proposed rights offering

30 Oct 2017

BRIEF-Biolase names John Beaver as Chief Financial Officer

* Biolase names John Beaver Senior Vice President, Chief Financial Officer Source text for Eikon: Further company coverage:

02 Oct 2017

BRIEF-BIOLASE ‍expects about $8 mln to $12 mln for rights offering to stockholders

* BIOLASE announces plans for rights offering to stockholders

29 Sep 2017

BRIEF-Laser-based communication networks specialist Mynaric plans IPO

* SPECIALIST IN LASER-BASED AIR AND SPACE COMMUNICATION NETWORKS PLANS IPO

27 Sep 2017

BRIEF-BIOLASE names Jonathan T. Lord chairman of the board

* BIOLASE Inc - ‍announced that on September 1, named Jonathan T. Lord, as its new chairman of board​

05 Sep 2017

BRIEF-BIOLASE Q2 loss per share $0.06

* Q2 revenue $12.6 million versus $13.8 million Source text for Eikon: Further company coverage:

08 Aug 2017

Earnings vs. Estimates